Bale T - Search Results

1

Value of [¹⁸F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab.

Graham MS, Krebs S, Bale T, Domfe K, Lobaugh SM, Zhang Z, Dunphy MP, Kaley T, Young RJ. Graham MS, et al. Among authors: bale t. Neurooncol Adv. 2020 Apr 15;2(1):vdaa050. doi: 10.1093/noajnl/vdaa050. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32642703 Free PMC article.

2

Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.

Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N, Zheng Y, Skakodub A, Mehta SA, Campos C, Hsieh WY, Selcuklu SD, Ling L, Meng F, Jing X, Samoila A, Bale TA, Tsui DWY, Grommes C, Viale A, Souweidane MM, Tabar V, Brennan CW, Reiner AS, Rosenblum M, Panageas KS, DeAngelis LM, Young RJ, Berger MF, Mellinghoff IK. Miller AM, et al. Nature. 2019 Jan;565(7741):654-658. doi: 10.1038/s41586-019-0882-3. Epub 2019 Jan 23. Nature. 2019. PMID: 30675060 Free PMC article.

3

Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma.

Schram AM, Jonsson P, Drilon A, Bale TA, Hechtman JF, Benayed R, Hanusch B, Young RJ, Grommes C, Ku N, Kaley T, Hyman DM, Taylor BS. Schram AM, et al. Among authors: bale ta. JCO Precis Oncol. 2018;2:PO.18.00089. doi: 10.1200/PO.18.00089. Epub 2018 Aug 8. JCO Precis Oncol. 2018. PMID: 31218270 Free PMC article. No abstract available.

4

Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2-wildtype astrocytomas.

Lin AL, Rosenblum M, Mellinghoff IK, Tabar VS, Ogilvie S, Schaff L, Yang TJ, Young RJ, Taylor BS, Jonsson P, Bale TA. Lin AL, et al. Brain Pathol. 2020 May;30(3):653-660. doi: 10.1111/bpa.12826. Epub 2020 Feb 12. Brain Pathol. 2020. PMID: 31984581 Free PMC article.

5

Preclinical and first-in-human-brain-cancer applications of [¹⁸F]poly (ADP-ribose) polymerase inhibitor PET/MR.

Young RJ, Demétrio De Souza França P, Pirovano G, Piotrowski AF, Nicklin PJ, Riedl CC, Schwartz J, Bale TA, Donabedian PL, Kossatz S, Burnazi EM, Roberts S, Lyashchenko SK, Miller AM, Moss NS, Fiasconaro M, Zhang Z, Mauguen A, Reiner T, Dunphy MP. Young RJ, et al. Among authors: bale ta. Neurooncol Adv. 2020 Sep 15;2(1):vdaa119. doi: 10.1093/noajnl/vdaa119. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 33392502 Free PMC article.

6

Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation.

Wilcox JA, Brown S, Reiner AS, Young RJ, Chen J, Bale TA, Rosenblum MK, Newman WC, Brennan CW, Tabar V, Beal K, Panageas KS, Moss NS. Wilcox JA, et al. J Neurooncol. 2021 Dec;155(3):277-286. doi: 10.1007/s11060-021-03872-x. Epub 2021 Oct 16. J Neurooncol. 2021. PMID: 34655373

7

Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients.

McKenney AS, Weg E, Bale TA, Wild AT, Um H, Fox MJ, Lin A, Yang JT, Yao P, Birger ML, Tixier F, Sellitti M, Moss NS, Young RJ, Veeraraghavan H. McKenney AS, et al. Among authors: bale ta. Adv Radiat Oncol. 2022 Feb 6;8(1):100916. doi: 10.1016/j.adro.2022.100916. eCollection 2023 Jan-Feb. Adv Radiat Oncol. 2022. PMID: 36711062 Free PMC article.

8

Leptomeningeal disease in histone-mutant gliomas.

Diaz M, Rana S, Silva Correia CE, Reiner AS, Lin AL, Miller AM, Graham MS, Chudsky S, Bale TA, Rosenblum M, Karajannis MA, Pentsova E. Diaz M, et al. Neurooncol Adv. 2023 May 29;5(1):vdad068. doi: 10.1093/noajnl/vdad068. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37346983 Free PMC article.

9

CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas.

Hickman RA, Gedvilaite E, Ptashkin R, Reiner AS, Cimera R, Nandakumar S, Price A, Vanderbilt C, Fahy T, Young RJ, Miller AM, Mellinghoff IK, Rosenblum MK, Ladanyi M, Arcila ME, Zhang Y, Brannon AR, Bale TA. Hickman RA, et al. Among authors: bale ta. Acta Neuropathol. 2023 Dec;146(6):845-847. doi: 10.1007/s00401-023-02639-0. Epub 2023 Oct 13. Acta Neuropathol. 2023. PMID: 37831210 Free PMC article. No abstract available.

10

Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma.

Bhatia A, Moreno R, Reiner AS, Nandakumar S, Walch HS, Thomas TM, Nicklin PJ, Choi Y, Skakodub A, Malani R, Prabhakaran V, Tiwari P, Diaz M, Panageas KS, Mellinghoff IK, Bale TA, Young RJ. Bhatia A, et al. Clin Cancer Res. 2024 Jan 5;30(1):106-115. doi: 10.1158/1078-0432.CCR-23-1180. Clin Cancer Res. 2024. PMID: 37910594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters